Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $1.56 Million - $2.28 Million
-563,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$1.71 - $4.14 $356,124 - $862,196
-208,260 Reduced 27.0%
563,000 $2.16 Million
Q1 2021

May 17, 2021

SELL
$0.85 - $5.27 $109,429 - $678,459
-128,740 Reduced 14.3%
771,260 $2.04 Million
Q3 2020

Nov 16, 2020

BUY
$0.36 - $0.53 $252,000 - $371,000
700,000 Added 350.0%
900,000 $349,000
Q1 2020

May 15, 2020

BUY
$0.56 - $1.62 $112,000 - $324,000
200,000 New
200,000 $127,000
Q3 2018

Nov 13, 2018

SELL
$3.4 - $4.84 $237,592 - $338,219
-69,880 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$3.03 - $4.98 $408,586 - $671,538
-134,847 Reduced 65.87%
69,880 $287,000
Q4 2017

Feb 14, 2018

SELL
$2.43 - $3.54 $121,500 - $177,000
-50,000 Reduced 19.63%
204,727 $545,000
Q3 2017

Nov 14, 2017

BUY
$2.22 - $3.2 $565,493 - $815,126
254,727
254,727 $813,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $363M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.